Labiba Mustabina Oishee is a highly skilled professional with extensive experience in business and clinical development within the pharmaceutical industry. Currently serving as a Senior Business and Clinical Development Associate at Renata Limited since March 2020, Labiba focuses on identifying and developing opportunities for novel drugs in Bangladesh to enhance patient compliance and clinical efficacy. Previous roles include Assistant Marketing Manager and Marketing Intern at Aurelia Bioscience Ltd, where creative content marketing for life sciences was prioritized. Additionally, Labiba has held positions in web and media management, research, and writing for prominent organizations, alongside academic credentials from the University of Nottingham and North South University in biopharmaceutical biotechnology and biochemistry.
This person is not in any teams
This person is not in any offices
Renata Limited
35 followers
Main Business: Manufacture and Marketing of Human Pharmaceuticals and Animal Therapeutics. We have two production sites. The Mirpur Site is 12 Acres and Rajendrapur Site is 17 Acres. History: The Company started its operations as Pfizer (Bangladesh) Limited in 1972. For the next two decades it continued as a highly successful subsidiary of Pfizer Corporation. However, by the late 1990s the focus of Pfizer had shifted from formulations to research. In accordance with this transformation, Pfizer divested its interests in many countries, including Bangladesh. Specifically, in 1993 Pfizer transferred the ownership of its Bangladesh operations to local shareholders, and the name of the company was changed to Renata Limited. In a gesture of corporate charity, Pfizer donated shares so that, along with a partial payment from the SAJIDA Foundation, 51% ownership of Renata Limited would be held by the Foundation. Today SAJIDA’s microfinance and micro-insurance programs support over 107,120 members and their families; thus far cumulative loan disbursement totals BDT 5,750 million. Currently, SAJIDA’s health program covers over 1 million beneficiaries by delivering services through two 70 bed hospitals, panel doctors in SAJIDA’s micro finance branches, and mobile health teams. To date, the SAJIDA Foundation holds the majority ownership in Renata Limited. To learn more please visit the foundation’s website: www.sajidafoundation.org